Funck, Jr. Robert E. is EXECUTIVE VICE PRESIDENT of ABBOTT LABORATORIES. Currently has a direct ownership of 211,341 shares of ABT, which is worth approximately $24 Million. The most recent transaction as insider was on Mar 01, 2019, when has been sold 1,002 shares (Common shares without par value) at a price of $78.0 per share, resulting in proceeds of $78,156. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 211K
0% 3M change
6.61% 12M change
Total Value Held $24 Million

Funck, Jr. Robert E. Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 01 2019
SELL
Open market or private sale
$78,156 $78.0 p/Share
1,002 Reduced 0.72%
138,991 Common shares without ...
Feb 28 2019
SELL
Payment of exercise price or tax liability
$361,436 $77.23 p/Share
4,680 Reduced 3.23%
139,993 Common shares without ...
Feb 22 2019
BUY
Grant, award, or other acquisition
-
23,344 Added 13.89%
144,673 Common shares without ...
Sep 05 2018
SELL
Payment of exercise price or tax liability
$1,593,930 $67.11 p/Share
23,751 Reduced 16.37%
121,329 Common shares without ...
Sep 05 2018
BUY
Exercise of conversion of derivative security
$917,280 $25.2 p/Share
36,400 Added 20.06%
145,080 Common shares without ...
Jun 05 2018
SELL
Payment of exercise price or tax liability
$542,791 $63.02 p/Share
8,613 Reduced 7.34%
108,680 Common shares without ...
Jun 05 2018
BUY
Exercise of conversion of derivative security
$333,056 $26.02 p/Share
12,800 Added 9.84%
117,293 Common shares without ...
Mar 01 2018
SELL
Open market or private sale
$71,968 $58.99 p/Share
1,220 Reduced 1.15%
104,493 Common shares without ...
Feb 28 2018
SELL
Payment of exercise price or tax liability
$160,700 $60.55 p/Share
2,654 Reduced 2.45%
105,713 Common shares without ...
Feb 16 2018
BUY
Grant, award, or other acquisition
-
20,030 Added 15.6%
108,367 Common shares without ...
Feb 28 2017
SELL
Payment of exercise price or tax liability
$170,111 $45.46 p/Share
3,742 Reduced 4.06%
88,337 Common shares without ...
Feb 23 2017
SELL
Open market or private sale
$1,160,250 $45.5 p/Share
25,500 Reduced 21.69%
92,079 Common shares without ...
Feb 23 2017
BUY
Exercise of conversion of derivative security
$680,850 $26.7 p/Share
25,500 Added 17.82%
117,579 Common shares without ...
Feb 17 2017
BUY
Grant, award, or other acquisition
-
7,060 Added 7.12%
92,079 Common shares without ...
Jul 25 2016
SELL
Open market or private sale
$1,154,544 $43.08 p/Share
26,800 Reduced 23.97%
85,019 Common shares without ...
Jul 25 2016
BUY
Exercise of conversion of derivative security
$676,700 $25.25 p/Share
26,800 Added 19.33%
111,819 Common shares without ...
Feb 29 2016
SELL
Open market or private sale
$52,387 $39.3 p/Share
1,333 Reduced 1.54%
85,019 Common shares without ...
Feb 29 2016
SELL
Payment of exercise price or tax liability
$112,158 $39.52 p/Share
2,838 Reduced 3.18%
86,352 Common shares without ...
Feb 19 2016
BUY
Grant, award, or other acquisition
-
9,505 Added 9.63%
89,190 Common shares without ...
FJR

Funck, Jr. Robert E.

EXECUTIVE VICE PRESIDENT
Abbott Park, IL

Track Institutional and Insider Activities on ABT

Follow ABBOTT LABORATORIES and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ABT shares.

Notify only if

Insider Trading

Get notified when an Abbott Laboratories insider buys or sells ABT shares.

Notify only if

News

Receive news related to ABBOTT LABORATORIES

Track Activities on ABT